A postulated mechanism of in vivo resistance to taxanes in melanoma is the action of drug efflux transporter proteins, chiefly P-glycoprotein (P-gp/multi-drug resistance protein 1/MDR1/ABCB1). Here, ABCB1 is linked to melanoma.